HNWA
ADCT icon

Henrickson Nauta Wealth Advisors’s ADC Therapeutics ADCT Stock Holding History

Henrickson Nauta Wealth Advisors’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,411
Closed -$68.7K – 108
2025
Q4 		$68.7K Buy
+19,411
New +$78.8K 0.01% 119

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Henrickson Nauta Wealth Advisors's ADCT Position: Q1 2026 in Review

Henrickson Nauta Wealth Advisors sold out of ADC Therapeutics (ADCT) in Q1 2026, closing a stake of 19,411 shares — an estimated $68.7K sold.

Henrickson Nauta Wealth Advisors first reported a position in ADCT in Q4 2025 and held it in 1 quarter. The position peaked at $68.7K in Q4 2025. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • Henrickson Nauta Wealth Advisors reported no remaining ADC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Henrickson Nauta Wealth Advisors sold 19,411 ADC Therapeutics shares in Q1 2026, an estimated $68.7K.
  • Henrickson Nauta Wealth Advisors first reported a position in ADC Therapeutics in Q4 2025 and held it in 1 quarter.
  • Henrickson Nauta Wealth Advisors's ADC Therapeutics position peaked at $68.7K in Q4 2025.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Henrickson Nauta Wealth Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.